190 related articles for article (PubMed ID: 21763585)
1. Sorafenib-induced eruption resembling pityriasis rubra pilaris.
Paz C; Querfeld C; Shea CR
J Am Acad Dermatol; 2011 Aug; 65(2):452-453. PubMed ID: 21763585
[No Abstract] [Full Text] [Related]
2. Array of cutaneous adverse effects associated with sorafenib.
Kong HH; Turner ML
J Am Acad Dermatol; 2009 Aug; 61(2):360-1. PubMed ID: 19615549
[No Abstract] [Full Text] [Related]
3. Invasive squamous cell carcinoma and sorafenib in a black patient.
Donaldson MR; Stetson CL; Smith JL
Arch Dermatol; 2011 Jan; 147(1):133-4. PubMed ID: 21242415
[No Abstract] [Full Text] [Related]
4. Sorafenib-induced eruptive melanocytic lesions.
Kong HH; Sibaud V; Chanco Turner ML; Fojo T; Hornyak TJ; Chevreau C
Arch Dermatol; 2008 Jun; 144(6):820-2. PubMed ID: 18559790
[No Abstract] [Full Text] [Related]
5. [Sorafenib: effectiveness versus safety. Prevention of hand-foot syndrome].
Delgado-Téllez L; Campos Fernández de Sevilla MA; Tutau F
Farm Hosp; 2009; 33(5):288-9. PubMed ID: 19775581
[No Abstract] [Full Text] [Related]
6. Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome.
Galán Brotons A; Borrás-Blasco J; Rosique-Robles JD; Vicent Verge JM; Casterá ME
Clin Transl Oncol; 2008 Dec; 10(12):844-6. PubMed ID: 19068457
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib].
Wollenberg A; Staehler M; Eames T
Hautarzt; 2010 Aug; 61(8):662-7. PubMed ID: 20631979
[TBL] [Abstract][Full Text] [Related]
8. Hand-foot and stump syndrome to sorafenib.
Lai SE; Kuzel T; Lacouture ME
J Clin Oncol; 2007 Jan; 25(3):341-3. PubMed ID: 17235051
[No Abstract] [Full Text] [Related]
9. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B; Kerr H
Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797
[TBL] [Abstract][Full Text] [Related]
10. Can sorafenib cause hypothyroidism?
Robinson SI; Hobday TJ; Sathananthan A; Morris JC; McWilliams RR
J Chemother; 2007 Jun; 19(3):352-3. PubMed ID: 17594936
[No Abstract] [Full Text] [Related]
11. Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism.
Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A
Ann Oncol; 2011 Apr; 22(4):988-990. PubMed ID: 21321087
[No Abstract] [Full Text] [Related]
12. [Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma].
Reig M; Matilla A; Bustamante J; Castells L; de La Mata M; Delgado M; Moreno JM; Forner A; Varela M
Gastroenterol Hepatol; 2010 Dec; 33(10):741-52. PubMed ID: 20851505
[No Abstract] [Full Text] [Related]
13. [Cutaneous side effects of sorafenib and sunitinib].
Autier J; Mateus C; Wechsler J; Spatz A; Robert C
Ann Dermatol Venereol; 2008 Feb; 135(2):148-53; quiz 147, 154. PubMed ID: 18342102
[No Abstract] [Full Text] [Related]
14. Pityriasis rubra pilaris with histologic features of lichen nitidus.
Rashidghamat E; Griffiths WA; Mellerio JE; Robson A
J Am Acad Dermatol; 2015 Aug; 73(2):336-7. PubMed ID: 26183985
[No Abstract] [Full Text] [Related]
15. Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis.
Salman A; Sonmez Y; Sahin H; Unal AU; Direskeneli H; Cinel L; Ergun T
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 27862745
[No Abstract] [Full Text] [Related]
16. Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
Pichard DC; Cardones AR; Chu EY; Dahut WL; Kong HH
JAMA Dermatol; 2016 Feb; 152(2):227-8. PubMed ID: 26422655
[No Abstract] [Full Text] [Related]
17. Sorafenib-induced severe acute hepatitis in a stable liver transplant recipient.
Herden U; Fischer L; Schäfer H; Nashan B; von Baehr V; Sterneck M
Transplantation; 2010 Jul; 90(1):98-9. PubMed ID: 20606568
[No Abstract] [Full Text] [Related]
18. Non-pigmenting fixed drug eruption induced by sorafenib.
Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
[No Abstract] [Full Text] [Related]
19. Keratoacanthomas associated with sorafenib therapy.
Kong HH; Cowen EW; Azad NS; Dahut W; Gutierrez M; Turner ML
J Am Acad Dermatol; 2007 Jan; 56(1):171-2. PubMed ID: 17190642
[No Abstract] [Full Text] [Related]
20. Queratosis Pilaris.
Pediatr Dermatol; 2019 Nov; 36(6):e106-e107. PubMed ID: 31778571
[No Abstract] [Full Text] [Related]
[Next] [New Search]